These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10750350)

  • 1. XE-CT CBF changes during normative aging, cognitive decline and dementia.
    Meyer JS; Rauch GM; Rauch RA; Haque A; Crawford K
    Keio J Med; 2000 Feb; 49 Suppl 1():A95-7. PubMed ID: 10750350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors accelerating cerebral degenerative changes, cognitive decline and dementia.
    Meyer JS; Rauch GM; Crawford K; Rauch RA; Konno S; Akiyama H; Terayama Y; Haque A
    Int J Geriatr Psychiatry; 1999 Dec; 14(12):1050-61. PubMed ID: 10607973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular and other risk factors for Alzheimer's disease and vascular dementia.
    Meyer JS; Rauch GM; Rauch RA; Haque A; Crawford K
    Ann N Y Acad Sci; 2000 Apr; 903():411-23. PubMed ID: 10818532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for cerebral hypoperfusion, mild cognitive impairment, and dementia.
    Meyer JS; Rauch G; Rauch RA; Haque A
    Neurobiol Aging; 2000; 21(2):161-9. PubMed ID: 10867201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for cerebral degenerative changes and dementia.
    Meyer JS; Terayama Y; Konno S; Akiyama H; Margishvili GM; Mortel KF
    Eur Neurol; 1998; 39 Suppl 1():7-16. PubMed ID: 9516069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral blood flow and brain atrophy correlated by xenon contrast CT scanning.
    Kitagawa Y; Meyer JS; Tanahashi N; Rogers RL; Tachibana H; Kandula P; Dowell RE; Mortel KF
    Comput Radiol; 1985; 9(6):331-40. PubMed ID: 3879209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal human aging: factors contributing to cerebral atrophy.
    Akiyama H; Meyer JS; Mortel KF; Terayama Y; Thornby JI; Konno S
    J Neurol Sci; 1997 Nov; 152(1):39-49. PubMed ID: 9395125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinguishing patients with senile dementia of Alzheimer type and normal elderly subjects utilizing xenon CT-CBF and multivariate analysis.
    Kobari M; Meyer JS; Ichijo M; Kawamura J
    Keio J Med; 2000 Feb; 49 Suppl 1():A101-4. PubMed ID: 10750352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modifiable vascular markers for cognitive decline and dementia: the importance of arterial aging and hemodynamic factors.
    Pase MP
    J Alzheimers Dis; 2012; 32(3):653-63. PubMed ID: 22810095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral blood flow in volunteers measured by PET and Xe CT/CBF. A comparison.
    Bergholt B; Ostergaard L; von Oettingen G; Johannsen P; Poulsen PH; Bundgaard H; Asboe H; Cold GE; Gjedde A; Gyldensted C; Astrup J
    Keio J Med; 2000 Feb; 49 Suppl 1():A55-7. PubMed ID: 10750338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive performance correlates with cerebrovascular impairments in multi-infarct dementia.
    Judd BW; Meyer JS; Rogers RL; Gandhi S; Tanahashi N; Mortel KF; Tawaklna T
    J Am Geriatr Soc; 1986 May; 34(5):355-60. PubMed ID: 3958410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral blood flow measurement by PET in hypertensive subjects as a marker of cognitive decline.
    Kitagawa K
    J Alzheimers Dis; 2010; 20(3):855-9. PubMed ID: 20182039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral hypoperfusion correlates with mild and parenchymal loss with severe multi-infarct dementia.
    Kawamura J; Meyer JS; Terayama Y; Weathers S
    J Neurol Sci; 1991 Mar; 102(1):32-8. PubMed ID: 1856730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study of cognitive function and onset of dementia in cognitively healthy elders.
    Rubin EH; Storandt M; Miller JP; Kinscherf DA; Grant EA; Morris JC; Berg L
    Arch Neurol; 1998 Mar; 55(3):395-401. PubMed ID: 9520014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral blood flow and cognitive testing correlate in Huntington's disease.
    Tanahashi N; Meyer JS; Ishikawa Y; Kandula P; Mortel KF; Rogers RL; Gandhi S; Walker M
    Arch Neurol; 1985 Dec; 42(12):1169-75. PubMed ID: 2933014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leuko-araiosis, cerebral atrophy, and cerebral perfusion in normal aging.
    Kobari M; Meyer JS; Ichijo M
    Arch Neurol; 1990 Feb; 47(2):161-5. PubMed ID: 2302088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive regional cerebral blood flow measurements in dementia.
    Yamaguchi F; Meyer JS; Yamamoto M; Sakai F; Shaw T
    Arch Neurol; 1980 Jul; 37(7):410-8. PubMed ID: 7387484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous sex hormones, cognitive decline, and future dementia in old men.
    Geerlings MI; Strozyk D; Masaki K; Remaley AT; Petrovitch H; Ross GW; White LR; Launer LJ
    Ann Neurol; 2006 Sep; 60(3):346-55. PubMed ID: 16865684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral circulation in the elderly.
    Meyer JS; Terayama Y; Takashima S
    Cerebrovasc Brain Metab Rev; 1993; 5(2):122-46. PubMed ID: 8329298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cognitive defects and regional cerebral blood flow in early dementia].
    Hagberg B
    Lakartidningen; 1974 Mar; 71(13):1288-90. PubMed ID: 4823613
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.